care+ medicines limited
care+ medicines limited Company Information
Company Number
11225883
Website
-Registered Address
ams accountants medical limited, floor 2, manchester, M1 3BE
Industry
Other human health activities
Dispensing chemist in specialised stores
Telephone
-
Next Accounts Due
June 2024
Group Structure
View All
Shareholders
alihussein dalal 50%
mehraan sattar 50%
care+ medicines limited Estimated Valuation
Pomanda estimates the enterprise value of CARE+ MEDICINES LIMITED at £1.8m based on a Turnover of £5.2m and 0.35x industry multiple (adjusted for size and gross margin).
care+ medicines limited Estimated Valuation
Pomanda estimates the enterprise value of CARE+ MEDICINES LIMITED at £1.4m based on an EBITDA of £376.1k and a 3.75x industry multiple (adjusted for size and gross margin).
care+ medicines limited Estimated Valuation
Pomanda estimates the enterprise value of CARE+ MEDICINES LIMITED at £1.6m based on Net Assets of £681.6k and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Care+ Medicines Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Care+ Medicines Limited Overview
Care+ Medicines Limited is a live company located in manchester, M1 3BE with a Companies House number of 11225883. It operates in the other human health activities sector, SIC Code 86900. Founded in February 2018, it's largest shareholder is alihussein dalal with a 50% stake. Care+ Medicines Limited is a young, mid sized company, Pomanda has estimated its turnover at £5.2m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Care+ Medicines Limited Health Check
Pomanda's financial health check has awarded Care+ Medicines Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 3 areas for improvement. Company Health Check FAQs
3 Strong
6 Regular
3 Weak
Size
annual sales of £5.2m, make it in line with the average company (£6.3m)
- Care+ Medicines Limited
£6.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 120%, show it is growing at a faster rate (5.2%)
- Care+ Medicines Limited
5.2% - Industry AVG
Production
with a gross margin of 34.8%, this company has a comparable cost of product (34.8%)
- Care+ Medicines Limited
34.8% - Industry AVG
Profitability
an operating margin of 7.2% make it as profitable than the average company (6.5%)
- Care+ Medicines Limited
6.5% - Industry AVG
Employees
with 7 employees, this is below the industry average (50)
7 - Care+ Medicines Limited
50 - Industry AVG
Pay Structure
on an average salary of £22.6k, the company has an equivalent pay structure (£22.6k)
- Care+ Medicines Limited
£22.6k - Industry AVG
Efficiency
resulting in sales per employee of £743.5k, this is more efficient (£90.4k)
- Care+ Medicines Limited
£90.4k - Industry AVG
Debtor Days
it gets paid by customers after 80 days, this is later than average (26 days)
- Care+ Medicines Limited
26 days - Industry AVG
Creditor Days
its suppliers are paid after 48 days, this is close to average (45 days)
- Care+ Medicines Limited
45 days - Industry AVG
Stock Days
it holds stock equivalent to 5 days, this is less than average (19 days)
- Care+ Medicines Limited
19 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 7 weeks, this is less cash available to meet short term requirements (69 weeks)
7 weeks - Care+ Medicines Limited
69 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 48.3%, this is a similar level of debt than the average (44.4%)
48.3% - Care+ Medicines Limited
44.4% - Industry AVG
care+ medicines limited Credit Report and Business Information
Care+ Medicines Limited Competitor Analysis
Perform a competitor analysis for care+ medicines limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
care+ medicines limited Ownership
CARE+ MEDICINES LIMITED group structure
Care+ Medicines Limited has no subsidiary companies.
Ultimate parent company
CARE+ MEDICINES LIMITED
11225883
care+ medicines limited directors
Care+ Medicines Limited currently has 2 directors. The longest serving directors include Mr Alihussein Dalal (Feb 2018) and Mr Mehraan Sattar (Feb 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Alihussein Dalal | United Kingdom | 38 years | Feb 2018 | - | Director |
| Mr Mehraan Sattar | England | 32 years | Feb 2018 | - | Director |
CARE+ MEDICINES LIMITED financials
Care+ Medicines Limited's latest turnover from September 2022 is estimated at £5.2 million and the company has net assets of £681.6 thousand. According to their latest financial statements, Care+ Medicines Limited has 7 employees and maintains cash reserves of £64.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Feb 2019 | |
|---|---|---|---|---|---|
| Turnover | |||||
| Other Income Or Grants | |||||
| Cost Of Sales | |||||
| Gross Profit | |||||
| Admin Expenses | |||||
| Operating Profit | |||||
| Interest Payable | |||||
| Interest Receivable | |||||
| Pre-Tax Profit | |||||
| Tax | |||||
| Profit After Tax | |||||
| Dividends Paid | |||||
| Retained Profit | |||||
| Employee Costs | |||||
| Number Of Employees | 7 | 10 | 7 | 2 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Feb 2019 | |
|---|---|---|---|---|---|
| Tangible Assets | 55,171 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 55,171 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 55,395 | 39,250 | 74,800 | 65,250 | 0 |
| Trade Debtors | 1,143,775 | 762,664 | 154,549 | 88,351 | 87,606 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 107,939 | 11,532 | 0 |
| Cash | 64,565 | 34,422 | 137 | 7,507 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,263,735 | 836,336 | 337,425 | 172,640 | 87,606 |
| total assets | 1,318,906 | 836,336 | 337,425 | 172,640 | 87,606 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 449,699 | 299,030 | 110,112 | 87,823 | 36,347 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 22,808 | 13,238 | 0 |
| total current liabilities | 449,699 | 299,030 | 132,920 | 101,061 | 36,347 |
| loans | 0 | 0 | 50,000 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 187,563 | 161,228 | 114,562 | 69,645 | 38,145 |
| provisions | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 187,563 | 161,228 | 164,562 | 69,645 | 38,145 |
| total liabilities | 637,262 | 460,258 | 297,482 | 170,706 | 74,492 |
| net assets | 681,644 | 376,078 | 39,943 | 1,934 | 13,114 |
| total shareholders funds | 681,644 | 376,078 | 39,943 | 1,934 | 13,114 |
| Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Feb 2019 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Profit | |||||
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 |
| Tax | |||||
| Stock | 16,145 | -35,550 | 9,550 | 65,250 | 0 |
| Debtors | 381,111 | 500,176 | 162,605 | 99,883 | 87,606 |
| Creditors | 150,669 | 188,918 | 22,289 | 87,823 | 36,347 |
| Accruals and Deferred Income | 0 | -22,808 | 9,570 | 13,238 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||
| Investing Activities | |||||
| capital expenditure | |||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||
| Financing Activities | |||||
| Bank loans | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | -50,000 | 50,000 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 26,335 | 46,666 | 44,917 | 69,645 | 38,145 |
| share issue | |||||
| interest | |||||
| cash flow from financing | |||||
| cash and cash equivalents | |||||
| cash | 30,143 | 34,285 | -7,370 | 7,507 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 |
| change in cash | 30,143 | 34,285 | -7,370 | 7,507 | 0 |
P&L
September 2022turnover
5.2m
+40%
operating profit
376.1k
0%
gross margin
34.8%
+8.69%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2022net assets
681.6k
+0.81%
total assets
1.3m
+0.58%
cash
64.6k
+0.88%
net assets
Total assets minus all liabilities
Similar Companies
care+ medicines limited company details
company number
11225883
Type
Private limited with Share Capital
industry
86900 - Other human health activities
47730 - Dispensing chemist in specialised stores
incorporation date
February 2018
age
6
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
ams accountants medical limited, floor 2, manchester, M1 3BE
last accounts submitted
September 2022
care+ medicines limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to care+ medicines limited.
care+ medicines limited Companies House Filings - See Documents
| date | description | view/download |
|---|
